Fortunately, we are making some progress as organizations such as the Partnership for Advancing Clinical Trials (PACT) ...
Florence has been issuing its State of Technology Enabled Clinical Trials Report for five years now, so there is contextual ...
In an interview with ACT senior editor Andy Studna at SCOPE Summit, Jonathan Norman, director, localization services, YPrime, discusses the importance of communicating with patients in their native ...
As clinical trial complexity, duration, and cost continue to rise, life sciences companies are turning to data to help them ...
In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, chief strategy officer, Cluepoints, ...
Based on our research, we estimate that the global investigative site community spent $170 million in 2024 to complete ...
Nevertheless, there is no question that the research credit provides significant tax savings and should be considered by ...
Gazyva/Gazyvaro (obinutuzumab) was found to significantly improve complete renal response in lupus nephritis patients, ...
In an interview with ACT senior editor Andy Studna at SCOPE Summit, Patil, vice president, digital innovation, IQVIA, ...
In an interview with ACT senior editor Andy Studna at SCOPE Summit, Tenaerts, chief scientific officer, Medable, highlights ...
Session explores innovation in operationalizing clinical trials and how challenges with adoption can be addressed.
Interactive panel on day 1 of SCOPE Summit 2025 highlighted the need for inclusive narratives, social listening to understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback